Ekso Bionics Unveils Presentation on Enhancing Human Function with Advanced Robotics
I'm PortAI, I can summarize articles.
Ekso Bionics Holdings Inc. has unveiled an investor presentation showcasing its advancements in health and quality of life through robotics, particularly in neuro-rehabilitation. The company has deployed over 1,000 exoskeleton devices across 500 centers globally. Plans include a limited research release in 2024 and a commercial launch of the NOMAD product in 2025. The acquisition of Indego and a CMS reimbursement strategy of $91,000 are also highlighted as part of their market expansion efforts.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments